GCM
Gables Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.35K | Hold |
200
| – | – | ﹤0.01% | 399 |
|
2025
Q1 | $3.07K | Hold |
200
| – | – | ﹤0.01% | 402 |
|
2024
Q4 | $4.41K | Hold |
200
| – | – | ﹤0.01% | 396 |
|
2024
Q3 | $3.6K | Hold |
200
| – | – | ﹤0.01% | 410 |
|
2024
Q2 | $3.25K | Hold |
200
| – | – | ﹤0.01% | 361 |
|
2024
Q1 | $2.82K | Hold |
200
| – | – | ﹤0.01% | 367 |
|
2023
Q4 | $2.09K | Hold |
200
| – | – | ﹤0.01% | 360 |
|
2023
Q3 | $2.04K | Hold |
200
| – | – | ﹤0.01% | 339 |
|
2023
Q2 | $1.51K | Hold |
200
| – | – | ﹤0.01% | 359 |
|
2023
Q1 | $1.77K | Hold |
200
| – | – | ﹤0.01% | 354 |
|
2022
Q4 | $1.82K | Hold |
200
| – | – | ﹤0.01% | 337 |
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 322 |
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 336 |
|
2022
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 334 |
|
2021
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 333 |
|
2021
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 337 |
|
2021
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 338 |
|
2021
Q1 | $2K | Hold |
200
| – | – | ﹤0.01% | 368 |
|
2020
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 347 |
|
2020
Q3 | $2K | Sell |
200
-3,000
| -94% | -$30K | ﹤0.01% | 354 |
|
2020
Q2 | $39K | Hold |
3,200
| – | – | 0.03% | 208 |
|
2020
Q1 | $29K | Buy |
3,200
+3,000
| +1,500% | +$27.2K | 0.02% | 227 |
|
2019
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 337 |
|
2019
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 346 |
|
2019
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 328 |
|
2019
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 326 |
|
2018
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 335 |
|
2018
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 335 |
|
2018
Q2 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 333 |
|